Medtronic (MDT) reported its Q2 2026 financial results on September 1, 2026, before the market open. The company reported earnings per share (EPS) of 1.45 USD, beating the analyst estimate of 1.39 USD by 4.4%. Revenue for the quarter reached 9756 million USD. Following the release, the stock price rose by 1.53%.
Generated automatically from our data — as of September 9, 2026
Key figures at a glance
Estimate (EPS): 1.39 USD
Reported (EPS): 1.45 USD
Price reaction: +1.5%
Frequently asked questions
Did Medtronic beat or miss earnings-per-share expectations?
Medtronic beat the analyst estimate of 1.39 USD earnings per share (Q2 2026) by 4.4%, reporting 1.45 USD.
How did Medtronic stock react to the earnings report?
Medtronic stock rose 1.5% on the trading day following the release.
What was Medtronic's revenue in Q2 2026?
Medtronic reported revenue of 9,756M USD in Q2 2026.